Mechanism of Action: Leukotriene Receptor Antagonists
✉ Email this page to a colleague
Drugs with Mechanism of Action: Leukotriene Receptor Antagonists
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dr Reddys Labs Ltd | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 090372-002 | Nov 18, 2010 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 213163-001 | Nov 27, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Annora Pharma | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 212475-001 | Sep 10, 2020 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Dr Reddys Labs Ltd | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 090372-001 | Nov 18, 2010 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| Aurobindo Pharma | ZAFIRLUKAST | zafirlukast | TABLET;ORAL | 213163-002 | Nov 27, 2023 | AB | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
